Point biopharma global inc.

Biotechnology

PNT


4850 West 78th Street Indianapolis
, IN

News

  • Point Biopharma Inc soared 84% to $12.23 after the company agreed to be acquired by Eli Lilly for $12.50 a share in cash or $1.4 billion. 

    Eli Lilly & Company decreased 1.1% to $532.39. 

    Oct 3, 2023

Executive/
Director

Links

Price

  • Last Close
  • $ 12.5
    $ +0.02 0.16 %
    Dec 26, 2023
  • 52-Week High/Low
  • $14.23 - $6.67
  • YTD
  • 0%

  • Trading Volume
  • 3,290,996
  • Market Cap Full
  • $
  • Shares Outstanding

  • Jan 1, 1970
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Q1 - - - - - - -24.7% 42.3% -0.3% -
Q2 - - - - - - -2.2% -14.6% 24.6% -
Q3 - - - - - 17.5% -25.2% 13.5% -26.4% -
Q4 - - - - - -3% -27.2% -5.7% 87% -
J F M A M J J A S O N D
2024 - - - - - - - - - - - -
2023 9.7% -6.4% -2.9% 6.5% 19.8% -2.3% -1.3% -11% -16.2% 89.8% 7.4% -8.1%
    2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
    0%0%0%0%0%0%0%-60%30%71%0%

Earnings

Q1
Q2
Q3
Q4
A

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover - - - - -
Total Asset Turnover 0.4 - - - -
Fixed Asset Turnover 4.8 - - - -
Leverage
Debt Ratio - - - - -
Debt – Equity Ratio - - - - -
Interest Coverage 4.5 - - - -
Equity multiplier 0.1 0.1 0.8 - -